Dextromethorphan hydrobromide 15 MG Chewable Tablet — RxCUI 2173731
RxNorm drug concept · Semantic clinical drug
RxCUI 2173731
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2173731
Official nameDextromethorphan hydrobromide 15 MG Chewable Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dextromethorphan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It won't necessarily silence your cough entirely, but it does temporarily suppress the cough reflex and reduce how intense and frequent your cough is. It can also help reduce that...
- What exactly does dextromethorphan do — will it stop my cough completely?
- It depends on your child's age and the specific product. Most dextromethorphan products should not be given to children under 4 years old without a doctor's guidance. Some products...
- This is a really important question. If your antidepressant is an MAOI (monoamine oxidase inhibitor), you absolutely cannot take dextromethorphan — not while you're on it, and not...
🕸️ Concept Web — How Dextromethorphan hydrobromide 15 MG Chewable Tab... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dextromethorphan hydrobromide 15 MG Chewable Tablet
RxCUI 2173731 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Dextromethorphan
3289IN -
Dextromethorphan hydrobromide
102490PIN
-
Dextromethorphan
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dextromethorphan Chewable Tablet
371756SCDF -
Dextromethorphan hydrobromide Chewable Tablet
2648579SCDFP -
Dextromethorphan Chewable Product
1295347SCDG -
Dextromethorphan Oral Product
1155547SCDG -
Dextromethorphan Pill
1155548SCDG -
Dextromethorphan hydrobromide Chewable Product
2660901SCDGP -
Dextromethorphan hydrobromide Oral Product
2660147SCDGP -
Dextromethorphan hydrobromide Pill
2663115SCDGP - +4 more in this family
-
Dextromethorphan Chewable Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dextromethorphan hydrobromide 15 MG
1089821SCDC
-
Dextromethorphan hydrobromide 15 MG
Showing up to 8 concepts per family — 11 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dextromethorphan hydrobromide 15 MG
SCDC · 1089821 -
Dextromethorphan Chewable Tablet
SCDF · 371756 -
Dextromethorphan hydrobromide Chewable Tablet
SCDFP · 2648579 -
Dextromethorphan Chewable Product
SCDG · 1295347 -
Dextromethorphan Oral Product
SCDG · 1155547 -
Dextromethorphan Pill
SCDG · 1155548 -
Dextromethorphan hydrobromide Chewable Product
SCDGP · 2660901 -
Dextromethorphan hydrobromide Oral Product
SCDGP · 2660147 -
Dextromethorphan hydrobromide Pill
SCDGP · 2663115
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 2173731 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00031-9310-10 | 10 TABLET, CHEWABLE in 1 BOTTLE (0031-9310-10) | ROBITUSSIN LONG-ACTING COUGH Soft CHEWS | Haleon US Holdings LLC | 2024-06-19 |
| 00031-9310-20 | 20 TABLET, CHEWABLE in 1 BOTTLE (0031-9310-20) | ROBITUSSIN LONG-ACTING COUGH Soft CHEWS | Haleon US Holdings LLC | 2024-06-19 |
Observed labelers:
Haleon US Holdings LLC (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.